Cost Effectiveness if Primary PCI Versus Thrombolytic Therapy in Acute STEMI in Assiut University Hospital

Cost Effectiveness of Primary PCI Versus Thrombolytic Therapy in STEMI in Assiut University Hospital

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03310437

Enrollment

200

Registered

2017-10-16

Start date

2018-02-07

Completion date

2020-10-01

Last updated

2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST Elevation Myocardial Infarction

Brief summary

Cost effectiveness between PPCI and thrombolytic therapy in STEMI patients without contraindications

Detailed description

Cost effectiveness between PPCI and thrombolytic therapy in STEMI patients 100 patient each within 90 m for PPCI and 6h for thrombolytic

Interventions

PROCEDUREPrimary PCI

Primary percutaneous coronary intervention in acute myocardial infarction patients

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* All PPCI patients within 90 minutes door to ballon. * All thrombolytic patient without contraindication ,within 6 golden hours of chest pain.

Exclusion criteria

* patients don't meet inclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Compare between PPCI and thrombolytic therapy regarding over all cost in STEMI patients	one year for collecting 100 patient for each arm with follow up 6 month	we will compare different outcomes in ST elevation myocardial infarction patients presented to our hospital who had recieved intervention (primary PCI ) versus thrombolytic as regarded in all over cost in egyptian pounds and follow up for 6 month

Countries

Egypt

Contacts

Primary ContactNahed Sameh

nahedsameh74@gmail.com01224721313

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026